PL402999A1 - New strains of Escherichia coli - Google Patents
New strains of Escherichia coliInfo
- Publication number
- PL402999A1 PL402999A1 PL402999A PL40299913A PL402999A1 PL 402999 A1 PL402999 A1 PL 402999A1 PL 402999 A PL402999 A PL 402999A PL 40299913 A PL40299913 A PL 40299913A PL 402999 A1 PL402999 A1 PL 402999A1
- Authority
- PL
- Poland
- Prior art keywords
- escherichia coli
- new strains
- coli
- unique genetic
- genetic properties
- Prior art date
Links
- 241000588724 Escherichia coli Species 0.000 title abstract 6
- 230000002068 genetic effect Effects 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 1
- 230000007923 virulence factor Effects 0.000 abstract 1
- 239000000304 virulence factor Substances 0.000 abstract 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Przedmiotem wynalazku są nowe szczepy z gatunku Escherichia coli (E.coli) posiadające unikalne właściwości genetyczne. Nowe szczepy Escherichia coli PL44, Escherichia coli PL53 Escherichia coli PL85 zdeponowane pod nmerami odpowiednio: B/00046, B/00047, B/00048 w Polskiej Kolekcji Mikroorganizmów we Wrocławiu posiadające unikalne właściwości genetyczne związane z kodowaniem czynnika wirulencji i właściwość tworzenia biofilmu.The present invention relates to new strains of the species Escherichia coli (E.coli) possessing unique genetic properties. New strains of Escherichia coli PL44, Escherichia coli PL53 Escherichia coli PL85 deposited under the following numbers: B / 00046, B / 00047, B / 00048 respectively in the Polish Microorganism Collection in Wrocław having unique genetic properties associated with virulence factor coding and biofilm-forming properties.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL402999A PL227910B1 (en) | 2013-03-05 | 2013-03-05 | New strains of Escherichia coli |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL402999A PL227910B1 (en) | 2013-03-05 | 2013-03-05 | New strains of Escherichia coli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL402999A1 true PL402999A1 (en) | 2014-09-15 |
| PL227910B1 PL227910B1 (en) | 2018-01-31 |
Family
ID=51519213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL402999A PL227910B1 (en) | 2013-03-05 | 2013-03-05 | New strains of Escherichia coli |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL227910B1 (en) |
-
2013
- 2013-03-05 PL PL402999A patent/PL227910B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL227910B1 (en) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014191359A9 (en) | Aptamers and use of the aptamers in the diagnosis and treatment of cancer | |
| MX2021004479A (en) | Biologicals and their use in plants. | |
| AU2017260389A1 (en) | Chimeric neurotoxins | |
| CY1125211T1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| EA201990566A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| MX2016009898A (en) | Treatments for resistant acne. | |
| PH12016501671B1 (en) | Novel polysaccharide and uses thereof | |
| IN2015DN03196A (en) | ||
| EA201991157A1 (en) | DELIVERY OF PROTEINS BASED ON BACTERIA ATTENUATED BY VIRULENCE | |
| EA201690280A1 (en) | COMPOSITIONS AND METHODS RELATED TO Dedicated ENDOPHITES | |
| MX372655B (en) | EXOPOLYSACCHARIDE FOR THE TREATMENT AND/OR CARE OF THE SKIN, CULTURE MEDIA AND COMPOSITIONS THEREOF. | |
| NZ750707A (en) | Cot modulators and methods of use thereof | |
| EP3845241A8 (en) | Long lasting effect of new botulinum toxin formulations | |
| NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
| EA201692025A1 (en) | DELIVERY OF PROTEINS, BASED ON BACTERIA | |
| MY191539A (en) | Streptococcal vaccine | |
| MX2017016401A (en) | Immunogenic compositions. | |
| EP4501949A3 (en) | Pneumolysin mutants and methods of use thereof | |
| MX362070B (en) | Tannin-containing polyols, their production and use. | |
| MX2015009251A (en) | Methods of treatment of fibrosis and cancers. | |
| IN2013MU03216A (en) | ||
| MY190543A (en) | Silazane-siloxane random copolymers, their production and use | |
| WO2015048523A3 (en) | Mutant chondroitinase abc i compositions and methods of their use | |
| MX2019002050A (en) | New bacteria. | |
| PH12017500084A1 (en) | Vitamin b2 and its use |